COOL-BP Study: Continuous Versus Occasional Blood Pressure Study
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Aktiia Bracelet
Sponsored by

About this trial
This is an interventional diagnostic trial for Hypertension focused on measuring hypertension
Eligibility Criteria
Inclusion Criteria:
- Fluent in written and spoken English
- Already enrolled in the Remote Hypertension Program
- Average of last 3 office blood pressures >140/90 mm Hg in last 18 months OR Last office blood pressure >140/90 mm Hg in last 6 months OR Referred by MD and last 1 blood pressure >130/80 mm Hg
- Own an iPhone
Exclusion Criteria:
- Tachycardia (heart rate at rest > 120bpm)
- Atrial fibrillation, persistent
- Severe heart failure (LVEF<35%)
- Pheochromocytoma
- Raynaud's disease
- Trembling and shivering
- Known pregnancy
- Breastfeeding
- Arteriovenous fistula
- Arm amputation
- Exfoliative skin disease
- Lymphoedema
- Known allergy to silicone
- Not Massachusetts resident
- Last MGB office visit >3 years
- No-MGB provider
- Terminal medical condition
- CKD 4-5 (eGFR ≤ 30 mL/mn)
Sites / Locations
- Harvard Medical School
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Patients with Aktiia bracelet
Arm Description
This is a prospective open-label single arm study. Study participants will wear the Aktiia bracelet for 6 months and will continue in parallel the procedures of the Remote Hypertension Program.
Outcomes
Primary Outcome Measures
Diastolic and Systolic Pressures differences between weekly Diastolic and Systolic pressures averages provided by Home Blood Pressure Monitoring and by Aktiia 24h data.
Diastolic and Systolic Pressures are measured weekly manually by traditional Home Blood Pressure Monitoring and continuously with the Aktiia bracelet.
Diastolic and Systolic Pressures differences between monthly Diastolic and Systolic pressures averages provided by Home Blood Pressure Monitoring and by Aktiia 24h data.
Diastolic and Systolic Pressures are measured monthly manually by traditional Home Blood Pressure Monitoring and continuously with the Aktiia bracelet.
Secondary Outcome Measures
Diastolic and Systolic Pressures Circadian profiles
Analysis of the evolution of Diastolic and Systolic Pressures circadian profiles of each patient during the study.
Quality of life surveys
Participants complete the same survey at Day 30, Day 60 and Day 180 to give a feedback on participants' satisfaction and comfort regarding Aktiia product compared to Home Blood Pressure monitoring. Part of answers to surveys are based on satisfaction scales from 0 to 10 where 0 = "bad" and 10 = "good".
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05211648
Brief Title
COOL-BP Study: Continuous Versus Occasional Blood Pressure Study
Official Title
COOL-BP Study: Continuous Versus Occasional Blood Pressure Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
February 10, 2022 (Actual)
Primary Completion Date
May 23, 2023 (Actual)
Study Completion Date
May 23, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Aktiia SA
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
5. Study Description
Brief Summary
The COOL-BP study is part of the Remote Hypertension Program and will investigate the data provided by Aktiia Bracelet (a cuffless Blood Pressure monitor at the wrist) when integrated into the Remote Hypertension Program.
The COOL BP study aims to compare weekly and monthly Blood Pressure averages measured manually by traditional Home Blood Pressure Monitoring to those measured automatically by the Aktiia bracelet.
Detailed Description
This is a prospective open-label single arm study. The investigational device of this study is the Aktiia Bracelet device. Aktiia Bracelet is a non-invasive blood pressure (BP) monitor intended to track systolic and diastolic Blood Pressure trends. The Aktiia Bracelet can also measure heart rate.
Participants who consent to participate in COOL-BP will be shipped an Aktiia device to participants' residence.
For 6 months, patient will continue the procedures of the Remote Hypertension Program in parallel to wearing the Aktiia Bracelet. The Remote Hypertension Program is run remotely according to a clinical algorithm, where study navigators contact patients at regular intervals and monitor symptoms by regular phone calls; laboratory tests are obtained to ensure safety of the protocol's prescribed medications. Any symptoms will be evaluated by the program nurse practitioner or physician and managed per standard of care. During the study, the patient completes several surveys to give opinion on Aktiia product versus Home Blood Pressure Monitoring.
Following six months of using the Aktiia.product, the participant's participation in this study will end. Participants continued participation in the Remote Hypertension Program will depend on whether participants have met the blood pressure goals outlined in that program.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
hypertension
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
This is a prospective open-label single arm study.
Masking
None (Open Label)
Allocation
N/A
Enrollment
55 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patients with Aktiia bracelet
Arm Type
Experimental
Arm Description
This is a prospective open-label single arm study. Study participants will wear the Aktiia bracelet for 6 months and will continue in parallel the procedures of the Remote Hypertension Program.
Intervention Type
Device
Intervention Name(s)
Aktiia Bracelet
Intervention Description
Aktiia Bracelet is a CE-marked medical device that will be used in accordance with its instructions for use. The optical signals at the wrist are recorded non-invasively by means by the Aktiia bracelet. The Blood Pressure measurements are further determined from these optical signals and are compared to weekly and monthly Blood Pressure averages measured manually by traditional Home Blood Pressure Monitoring.
Primary Outcome Measure Information:
Title
Diastolic and Systolic Pressures differences between weekly Diastolic and Systolic pressures averages provided by Home Blood Pressure Monitoring and by Aktiia 24h data.
Description
Diastolic and Systolic Pressures are measured weekly manually by traditional Home Blood Pressure Monitoring and continuously with the Aktiia bracelet.
Time Frame
6 months
Title
Diastolic and Systolic Pressures differences between monthly Diastolic and Systolic pressures averages provided by Home Blood Pressure Monitoring and by Aktiia 24h data.
Description
Diastolic and Systolic Pressures are measured monthly manually by traditional Home Blood Pressure Monitoring and continuously with the Aktiia bracelet.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Diastolic and Systolic Pressures Circadian profiles
Description
Analysis of the evolution of Diastolic and Systolic Pressures circadian profiles of each patient during the study.
Time Frame
6 months
Title
Quality of life surveys
Description
Participants complete the same survey at Day 30, Day 60 and Day 180 to give a feedback on participants' satisfaction and comfort regarding Aktiia product compared to Home Blood Pressure monitoring. Part of answers to surveys are based on satisfaction scales from 0 to 10 where 0 = "bad" and 10 = "good".
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
26 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Fluent in written and spoken English
Already enrolled in the Remote Hypertension Program
Average of last 3 office blood pressures >140/90 mm Hg in last 18 months OR Last office blood pressure >140/90 mm Hg in last 6 months OR Referred by MD and last 1 blood pressure >130/80 mm Hg
Own an iPhone
Exclusion Criteria:
Tachycardia (heart rate at rest > 120bpm)
Atrial fibrillation, persistent
Severe heart failure (LVEF<35%)
Pheochromocytoma
Raynaud's disease
Trembling and shivering
Known pregnancy
Breastfeeding
Arteriovenous fistula
Arm amputation
Exfoliative skin disease
Lymphoedema
Known allergy to silicone
Not Massachusetts resident
Last MGB office visit >3 years
No-MGB provider
Terminal medical condition
CKD 4-5 (eGFR ≤ 30 mL/mn)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Naomi Fisher, MD
Organizational Affiliation
Harvard Medical School Boston MA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Harvard Medical School
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
COOL-BP Study: Continuous Versus Occasional Blood Pressure Study
We'll reach out to this number within 24 hrs